Gujarat Themis Biosyn (NSE:GUJTHEM) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GUJTHEM Gujarat Themis Biosyn Ltd NSE:GUJTHEM
64 GF Score
Price ₹363.95
GF Value ₹312.84
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Gujarat Themis Biosyn Valuation Rank Related Terms

NSE:GUJTHEM
64GF Score
Gujarat Themis Biosyn Ltd NSE:GUJTHEM
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gujarat Themis Biosyn (NSE:GUJTHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued. The current stock price of ₹363.95 is trading 16.3% above its estimated GF Value™ of ₹312.84. GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.

Key valuation signals for NSE:GUJTHEM:

  • Valuation Rank:
  • GF Value™: ₹312.84 vs. price of ₹363.95 (16.3% above fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the NSE:GUJTHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gujarat Themis Biosyn Business Description

Other Exchanges 506879:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
64GF Score

Get the complete analysis for NSE:GUJTHEM

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹363.95
Price
₹312.84
GF Value